Pharma Mar | PHM - 债务

金融业

EUR

EUR 395.08M

现金及等价物

EUR 17.82M

EUR 3.77M

EUR 283.42M

EUR 93.88M

EUR 49.42M

股息收益率

0.88

EUR 43.61M

EUR 44.96M

EPS每股收益

EUR 3.34

股本和储备

EUR 251.83M

EUR 86.7M

债务利息支出

EUR 117K

EUR 1.63M

EUR 36.68M

EUR 1.53B

EUR 59.67M

EUR 46.87M

EUR 43.61M

普通股股本

EUR 17.36M

17.41

EUR 40.2M

EUR 90.2M

销售和管理费用

EUR 17.31M

EUR 50.64M

贸易债权人

EUR 54.34M

应收帐款人

EUR 60.6M

	债务	更改		日
Akebia Therapeutics	USD 46.51M		7.82M	2025-03
Alaunos Therapeutics	USD 10.99M		5.78M	2023-03
Almirall	EUR 342.86M		61.94M	2025-12
Avita Medical	AUD 46.05M		1.46M	2025-12
Dianthus Therapeutics	USD 1.28M		45K	2025-09
Ionis Pharmaceuticals	USD 2.33B		1.1B	2025-12
IQVIA Holdings	USD 15.72B		767M	2025-12
Laboratorios Farma	EUR 129.3M		14.89M	2025-06
Moderna	USD 734M		7M	2025-09
Organon & Co	USD 8.83B		68M	2025-09
Pharma Mar	EUR 49.42M		1.98M	2025-12
Revvity	USD 3.37B		5.86M	2025-09
Tectonic Therapeutic	USD 876K		115K	2024-12
Viatris	USD 14.41B		25.6M	2025-12
Xeris Pharmaceuticals	USD 257.65M		431K	2025-09